| Literature DB >> 19423657 |
Jong-In Kim1, Myeong Soo Lee, Dong-Hyo Lee, Kate Boddy, Edzard Ernst.
Abstract
The objective of this study was to assess the evidence for or against the effectiveness of cupping as a treatment option for pain. Fourteen databases were searched. Randomized clinical trials (RCTs) testing cupping in patients with pain of any origin were considered. Trials using cupping with or without drawing blood were included, while trials comparing cupping with other treatments of unproven efficacy were excluded. Trials with cupping as concomitant treatment together with other treatments of unproven efficacy were excluded. Trials were also excluded if pain was not a central symptom of the condition. The selection of studies, data extraction and validation were performed independently by three reviewers. Seven RCTs met all the inclusion criteria. Two RCTs suggested significant pain reduction for cupping in low back pain compared with usual care (P < .01) and analgesia (P < .001). Another two RCTs also showed positive effects of cupping in cancer pain (P < .05) and trigeminal neuralgia (P < .01) compared with anticancer drugs and analgesics, respectively. Two RCTs reported favorable effects of cupping on pain in brachialgia compared with usual care (P = .03) or heat pad (P < .001). The other RCT failed to show superior effects of cupping on pain in herpes zoster compared with anti-viral medication (P = .065). Currently there are few RCTs testing the effectiveness of cupping in the management of pain. Most of the existing trials are of poor quality. Therefore, more rigorous studies are required before the effectiveness of cupping for the treatment of pain can be determined.Entities:
Year: 2011 PMID: 19423657 PMCID: PMC3136528 DOI: 10.1093/ecam/nep035
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Summary of randomized clinical trials of cupping for pain conditions.
| First author (year) (ref.), Country | Sample size condition/disease duration | Intervention (regimen) | Control (regimen) | Total session | Pain related main outcome | Main results | Measurement time | Risk of bias |
|---|---|---|---|---|---|---|---|---|
| Huang (2006) [ | 60/cancer pain/5–17 months | (A) Dry-cupping (maintain: 5 min, repeat + maintain: 10–15 min, once a day for 3 days, | (B) Opioid (Propoxyphene Napsylate and Paracetamol, two tablets, three times daily for 3 days, | 3 | (1) Response rate (% reduction of pain ≥ 70%) (2) Pain free duration (h), |
(1) A (28/30, 67%); B (13/30, 43%), | Baseline: before intervention Post: after final intervention | (Y,U,U,U,U) |
| Hong (2006) [ | 70/non-specific low back pain/1 week to 3.1 years | (A) Dry cupping (moving cupping, 5 min, 1/2 days for 11 days, | (B) NSAIDs (Dexibuprofen, 0.15 g, three times daily for 12 days, | 6 | (1) Pain on VAS (100 mm) (2) Response rate (% change of VAS ≥ 80%) |
(1) Mean difference 22.8 (95% CI, 11.4–34.2), | Baseline: before intervention Post: after final intervention | (Y,Y,U,U,U,U) |
| Zhang (1997) [ | 45/acute trigeminal neuralgia/6 days to 4 years | (A) Wet-cupping (15 min, once a day for 6 days and then once every other day for three sessions, | (B) Analgesics (AP-237 50 mg (IM, only first day) and then 60 mg (oral, three times daily for 12 days), | 9 | Response rate | A (28/30, 93%); B(7/15, 47%), | Baseline: before intervention Post: after final intervention | (Y,U,U,U,U,U) |
| Farhadi (2009) [ | 98/non-specific low back pain/≥4 weeks |
(A) Wet-cupping (20 min, three stage, 3 days intervals, | (B) Usual care ( | 3 | PPI of the MPQ (6-point Likert scale) | Mean difference 2.2 points (95% CI, 1.7–2.6), | Baseline: before start trial Post: 3 months after final intervention | (Y,Y,Y,U,U,Y) |
| Lüdtke (2006) [ | 20/BPN/n.r. | (A) Wet-cupping (10 min, once, |
(B) Usual care (analgesics, physiotherapies, psychological care, musicotherapy, | 1 | Pain in Brachialgia Score (NAS, 10-point Likert scale) | Mean difference 1.6 (95% CI, 0.13–3.07), | Baseline: mean 7 days pre-treatment score (days 1–7) Post: mean 7 daily post-treatment score (days 9–15) | (A,A,A,U,U,A) |
| Michalsen (2007) [ | 52/BPN/n.r. | (A) Wet-cupping (10 min, once, | (B) Heat pad ( | 1 | (1) Pain in Brachialgia Score (100 mm VAS) (2) Neck pain (100 mm VAS) | (1) Mean difference 22.9 (95% CI, 10.5–35.3), | Baseline: pre-treatment Post: 7 day after treatment | (Y,Y,U,U,Y,Y) |
| Xu (2004) [ | 80/Herpes zoster/1–3 days | (A) Wet-cupping (15 min, once a day for 7 days, | (B) Anti viral (Aciclovir 0.5 g + 5% DW 250 ml (IV), plus Aciclovir cream (external use), two times daily for 7 days, | 7 | Response rate (% degree of pain ≥ 60%) | 40/40, 100%); B (35/40, 88%), | Baseline: before intervention Post: after final intervention | (Y,U,U,U,U,U) |
Risk of bias (randomization, randomization method, drop-out or withdraw, patient blind, assessor blind, allocation concealment). Y: low risk of bias; U: unclear; N: high risk of bias; BPN: Brachialgia paraesthetica nocturna; MPQ: McGill Pain Questionnaire; NAS: Numeric Analogue Scale; n.r.: not reported; NS: not significant; NSAID: non-steroidal anti-inflammatory drug; PPI: Present Pain Intensity; VAS: Visual analogue scale.
aThe authors were contacted and details were based on information from them.
Figure 1Flowchart of trial selection process. RCT: randomized clinical trial; CCT: non-randomized controlled clinical trial; UCT: uncontrolled clinical trial.
Summary of treatment points, their rationales and adverse events.
| First author (year) (ref.) | Conditions | Cupping point | Rationales | Adverse effects |
|---|---|---|---|---|
| Huang (2006) [ | Cancer pain | Liver cancer: ST36, SP6 or LR14, BL18 Lung cancer: BL13, CV17 or BL15 Large intestine cancer: CV8, BL25 or ST36 Bone Metastases: BL23, ST36, SP6 or Asihyeol (unfixed point) Gastric cancer: CV8, BL21, and so forth. | TCM theory | n.r. |
| Hong (2006) [ | Low back pain | Bladder Meridian (BL12–BL27) | TCM theory | n.r.(−) |
| Zhang (1997) [ | Acute trigeminal neuralgia | GV14, BL13 (bilateral) | Experience of veteran TCM doctors | n.r. |
| Farhadi (2008) [ | Low back pain | Day 0: Between the two scapulas, opposite to T1–T3 Scapular spine Day 3: The sacrum area, between the lumbar vertebrae and the coccyx bone Day 6: The calf area, in the middle surface of gastrocnemius muscle | Traditional Iranian medicine | Vaso-vagal shock ( |
| Ludtke (2006) [ | Brachialgia paraesthetica nocturna | The skin at the shoulder triangle (over the Musculus trapezius) | Empirical data | None |
| Michalsen (2007) [ | Brachialgia paraesthetica nocturna (neurologically confirmed carpel tunnel syndrome) | The skin at the shoulder triangle (over the Musculus trapezius) | Empirical data | n.r. |
| Xu (2004) [ | Herpes zoster | Lesion (the surface of vesicle or erythema and painful place) | TCM theory | n.r. |
TCM: Traditional Chinese medicine, n.r.: not reported.
aThe authors were contacted and details were based on information from them.